About Us

BIOTECH LABORATORIUM LTD is a modern pharmaceutical company based in London, United Kingdom. We focus on scientific research and the development of innovative medicinal products in collaboration with leading global manufacturers. While the company itself is young, our team is composed of highly experienced professionals with many years of expertise in pharmaceuticals, biotechnology, and regulatory compliance. Their knowledge enables us to develop effective, safe, and internationally compliant treatments.

At the heart of our operations is our London-based laboratory, where we carry out scientific research, pharmaceutical formulation, and analytical testing. Our work adheres strictly to Good Manufacturing Practice (GMP) standards and follows the guidance of the Medicines and Healthcare products Regulatory Agency (MHRA), ensuring a consistently high level of quality and safety. We build strategic partnerships with global manufacturers, research institutions, and distributors, allowing us to provide access to advanced pharmaceutical solutions that meet the evolving needs of healthcare systems worldwide.

At BIOTECH LABORATORIUM LTD, we are committed to sustainability, environmental responsibility, and ethical business practices. Our mission is not only to develop effective therapies but to do so with integrity, transparency, and respect for society and the planet.

Our research and development efforts are already gaining recognition internationally, earning the trust of healthcare professionals and patients alike. We take pride in contributing to better health outcomes by combining scientific excellence, international collaboration, and a commitment to continuous improvement.

About the Product

Omnitida BioActive is an innovative medication based on tirzepatide, designed to effectively support weight management. Thanks to its unique dual action mechanism — activating GIP and GLP-1 receptors — Omnitida helps control appetite, improves metabolism, and promotes natural weight loss.

This medication offers convenient use: a once-weekly injection provides long-lasting and stable effects, significantly enhancing comfort and adherence to treatment. Omnitida is suitable for adults with overweight and obesity, as well as those seeking to improve their quality of life through controlled weight reduction.

Omnitida BioActive is your reliable partner on the path to health and body harmony.

Omnitida BioActive

Ingredients & Key Facts

Active ingredient: Tirzepatide

Omnitida contains tirzepatide, a synthetic peptide that activates two incretin receptors: GIP and GLP-1. Thanks to its modified structure (39 amino acids and a C20 fatty acid chain), tirzepatide binds to albumin, enabling long-acting, once-weekly dosing.

It helps to:

  • Stimulate insulin secretion in response to glucose
  • Lower glucagon levels
  • Support weight reduction
Dual-receptor action

Tirzepatide activates both GIP and GLP-1 receptors, enhancing the body’s natural hormonal response to food.

This dual mechanism provides:

  • Improved blood glucose control in type 2 diabetes
  • Appetite suppression and weight loss support
  • Low risk of hypoglycaemia (when not used with insulin or sulfonylureas)
Omnitida 5 BioActive
FLEXIBLE DOSING REGIMEN

Omnitida allows for personalised treatment with a stepwise titration approach to improve tolerability:

  • Low risk of hypoglycaemia (when not used with insulin or sulfonylureas)
  • Titration: increase by 2.5 mg every 4 weeks
  • Maximum dose: 15 mg once weekly
  • Maintenance dose: 5 mg, 10 mg or 15 mg weekly, as prescribed by a healthcare professional
  • Administered subcutaneously (abdomen, thigh, or upper arm)
  • Can be injected at any time of day, with or without food
What’s in the kit

Each Omnitida kit includes:

  • 1 pre-filled syringe containing one of the following doses:
  • 2.5 mg / 5 mg / 10 mg / 15 mg of tirzepatide
  • 1 alcohol swab
  • Patient information leaflet with usage instructions
Faq

Get Every Answers From Here.

The Omnitida BioActive Injection Pen Kit is one of the most advanced medical solutions for weight management available today.

It contains tirzepatide, a next-generation medication that works by suppressing appetite and supporting significant, sustainable weight loss.

Tirzepatide mimics the action of two natural hormones — GLP-1 and GIP — which help regulate appetite and promote feelings of fullness after eating smaller portions.

Commonly known as “Mounjaro” in other markets, this dual-receptor agonist offers powerful metabolic benefits when used alongside a healthy diet and lifestyle.

Each pen kit is designed to provide several weeks of therapy, with the exact duration depending on the prescribed dosing schedule.

The Omnitida BioActive Injection Pen Kit offers a range of benefits for individuals seeking effective medical support for weight management:

  • Clinically proven weight loss – Tirzepatide helps significantly reduce body weight by lowering appetite and food intake.
  • Dual-receptor action – Activates both GLP-1 and GIP receptors, enhancing the body's natural satiety signals.
  • Once-weekly dosing – Designed for convenient, long-acting use with just one injection per week.
  • Appetite regulation – Promotes a lasting feeling of fullness after smaller meals, making it easier to maintain dietary changes.
  • Flexible titration – Allows gradual dose increases for better tolerability and individualised treatment.
  • User-friendly format – Pre-filled pens enable easy at-home use with no need for mixing or measuring.

When combined with healthy eating and physical activity, Omnitida can support long-term, sustainable weight loss.

As with most medications, some individuals may experience side effects while using Omnitida. The most commonly reported is nausea.

These effects are typically mild to moderate in nature and tend to subside as the body adjusts to treatment.

For a full list of possible side effects, including rare and uncommon reactions, please refer to the patient information leaflet provided in the kit. If you have any concerns, consult your healthcare professional.

  • 1 pre-filled injection pen with the prescribed dose of tirzepatide
  • 1 alcohol swab for skin preparation
  • A patient information leaflet with full instructions for use, storage, and safety

Omnitida BioActive contains tirzepatide, an innovative medication that mimics two natural hormones in the body — GLP-1 and GIP. These hormones regulate appetite and blood sugar levels after eating.

By activating both receptors, Omnitida BioActive:

  • Reduces hunger and cravings
  • Enhances the feeling of fullness after smaller meals
  • Supports sustained weight loss when used alongside a healthy lifestyle

Omnitida BioActive is intended for adults who require medical support in managing their weight. It may be suitable for people who:

  • Have a BMI of 30 or above (obesity), or
  • Have a BMI of 27 or above with weight-related conditions such as high blood pressure, high cholesterol, or sleep apnoea.

Omnitida BioActive should only be used under medical supervision and with a valid prescription.

Omnitida BioActive is administered as a subcutaneous injection once per week.

  • Injection sites include the abdomen, thigh, or upper arm
  • Rotate injection sites with each dose to avoid irritation
  • It can be taken at any time of day, with or without food
  • Always follow the instructions provided in the leaflet or by your healthcare professional

  • Take the missed dose as soon as possible within 4 days (96 hours)
  • If more than 4 days have passed, skip the missed dose and continue with your next dose as scheduled
  • Never take two doses less than 3 days (72 hours) apart

If you are unsure, consult your healthcare provider before your next injection.

  • In the refrigerator at 2°C to 8°C
  • Do not freeze
  • Protect from direct light
  • Keep in the original packaging until use
  • Keep out of reach of children

Do not use if the product has been frozen, damaged, or discoloured.

Results vary between individuals. Many users notice a reduction in appetite and changes in eating habits within the first few weeks.

Significant and sustained weight loss generally occurs gradually over several months, especially when combined with a healthy diet and regular exercise.

Consistency is key — follow your prescribed schedule and stay in contact with your healthcare provider for the best outcomes.

Product Info

OMNITIDA 2.5 BIOACTIVE PEN KIT

Omnitida 2.5 BioActive is a pre-filled injection pen containing a total of 10 mg of tirzepatide, delivered in four weekly doses of 2.5 mg each. It supports weight management by mimicking the body’s natural GLP-1 and GIP hormones to enhance satiety. One pen typically provides treatment for about 4 weeks. Always consult a healthcare professional before use.

  • Active ingredient Tirzepatide 10 mg per pen (4 doses of 2.5 mg each)
  • Dosing options 2.5 mg once weekly (initiation dose)
  • Kit contents 1 pre-filled syringe of Omnitida 5 BioActive, one alcohol pad, and instructions for use
  • Guidance Use under medical supervision; prescription required in Germany
  • Availability Use under medical supervision; prescription required in Germany
Product Info

Omnitida 5 BioActive pen kit

Omnitida 5 BioActive is a pre-filled injection pen containing a total of 20 mg of tirzepatide, delivered in four weekly doses of 5 mg each. It supports weight management by mimicking the body’s natural GLP-1 and GIP hormones to enhance satiety. One pen typically provides treatment for about 4 weeks. Always consult a healthcare professional before use.

  • Active ingredient Tirzepatide 20 mg per pen (4 doses of 5 mg each)
  • Dosing options 5 mg once weekly
  • Kit contents 1 pre-filled syringe of Omnitida 5 BioActive, one alcohol pad, and instructions for use
  • Guidance Use under medical supervision; prescription required in Germany
  • Availability Available at selected pharmacies and clinics (region dependent)
Product Info

OMNITIDA 10 BIOACTIVE PEN KIT

Omnitida 10 BioActive is a pre-filled injection pen containing a total of 40 mg of tirzepatide, delivered in four weekly doses of 10 mg each. It supports weight management by mimicking the body’s natural GLP-1 and GIP hormones to enhance satiety. One pen typically provides treatment for about 4 weeks. Always consult a healthcare professional before use.

  • Active ingredient Tirzepatide 40 mg per pen (4 doses of 10 mg each)
  • Dosing options 10 mg once weekly
  • Kit contents 1 pre-filled syringe of Omnitida 10 BioActive, one alcohol pad, and instructions for use
  • Guidance Use under medical supervision; prescription required in Germany
  • Availability Available at selected pharmacies and clinics (region dependent)
Product Info

OMNITIDA 15 BIOACTIVE PEN KIT

Omnitida 15 BioActive is a pre-filled injection pen containing a total of 60 mg of tirzepatide, delivered in four weekly doses of 15 mg each. It supports weight management by mimicking the body’s natural GLP-1 and GIP hormones to enhance satiety. One pen typically provides treatment for about 4 weeks. Always consult a healthcare professional before use.

  • Active ingredient Tirzepatide 60 mg per pen (4 doses of 15 mg each)
  • Dosing options 15 mg once weekly
  • Kit contents 1 pre-filled syringe of Omnitida 15 BioActive, one alcohol pad, and instructions for use
  • Guidance Use under medical supervision; prescription required in Germany
  • Availability Available at selected pharmacies and clinics (region dependent)

Contact Information

Biotech Laboratorium LTD
  • 71-75 Shelton Street,
    Covent Garden,
    London, England, WC2H 9JQ
  • Email: info@biotechlab.uk
  • Website: biotechlab.uk